- Home
- QNCX vs SMTI Comparison
QNCX vs SMTI Comparison
Compare QNCX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | SMTI |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 182.6M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | QNCX | SMTI |
|---|---|---|
| Price | $0.10 | $20.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $10.00 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 134.5M | 52.4K |
| Earning Date | 05-19-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $20.66 |
| Revenue Next Year | N/A | $13.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $0.09 | $18.29 |
| 52 Week High | $4.55 | $35.70 |
Technical Indicators
Market Signals| Indicator | QNCX | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 27.56 | 52.03 |
| Support Level | N/A | $20.12 |
| Resistance Level | $0.98 | $21.18 |
| Average True Range (ATR) | 0.02 | 1.09 |
| MACD | 0.10 | 0.09 |
| Stochastic Oscillator | 12.00 | 86.29 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.